Hybrid Conference (In Person / Virtual)

International Conference on DNA Sequencing, Evolutionary Biology and Applications (ICDSEBA - 27)
18th - 19th May 2027 , Riga, Latvia
** Important Notice      Beware of fraudulent emails and calls impersonating IIRD Conference to collect conference and journal fees. Ensure all payments are processed only through our official event website. Report suspicious activity to [email protected].

Conference Session Tracks

SDG Wheel

Aligned with

UN Sustainable Development Goals

This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.

SDG 3 SDG 3 — Good Health and Well-being
SDG 4 SDG 4 — Quality Education
SDG 9 SDG 9 — Industry, Innovation and Infrastructure
Session Tracks
Track 01
Advancements in DNA Sequencing Technologies

This track will explore the latest innovations in DNA sequencing methodologies, including next-generation sequencing and third-generation techniques. Participants will discuss the implications of these advancements for genomic research and personalized medicine.

Track 02
Genomic Data Analysis and Interpretation

This session focuses on the bioinformatics tools and statistical methods used to analyze genomic data. Researchers will share insights on data interpretation challenges and the integration of multi-omics approaches.

Track 03
Evolutionary Genomics: Mechanisms and Patterns

This track will delve into the evolutionary mechanisms that shape genomic diversity across species. Presentations will highlight case studies that illustrate the role of natural selection, genetic drift, and gene flow in evolution.

Track 04
Applications of CRISPR Technology in Genetics

This session will discuss the transformative impact of CRISPR-Cas9 technology on genetic engineering and gene therapy. Experts will present novel applications and ethical considerations surrounding genome editing.

Track 05
Population Genomics and Conservation Biology

This track will examine the role of population genomics in understanding biodiversity and informing conservation strategies. Participants will share research on genetic diversity, population structure, and the effects of climate change.

Track 06
Epigenetics: Mechanisms and Implications

This session will explore the field of epigenetics, focusing on the mechanisms that regulate gene expression without altering the DNA sequence. Discussions will include the implications of epigenetic modifications in development, disease, and evolution.

Track 07
Microbial Genomics and Evolutionary Dynamics

This track will highlight the genomic analysis of microbial communities and their evolutionary dynamics. Researchers will present findings on microbial evolution, adaptation, and the implications for human health and the environment.

Track 08
Comparative Genomics: Insights into Evolution

This session will focus on comparative genomics as a tool for understanding evolutionary relationships among species. Presentations will showcase how genomic comparisons can reveal evolutionary adaptations and functional innovations.

Track 09
Synthetic Biology: Designing New Biological Systems

This track will explore the principles and applications of synthetic biology in designing and constructing new biological systems. Participants will discuss the potential of synthetic organisms for biotechnology and environmental applications.

Track 10
Genetic Basis of Complex Traits and Diseases

This session will investigate the genetic underpinnings of complex traits and diseases, integrating genetic, environmental, and epigenetic factors. Researchers will share findings from genome-wide association studies and their implications for precision medicine.

Track 11
Ethics and Societal Implications of Genetic Research

This track will address the ethical considerations and societal implications arising from advancements in genetic research and biotechnology. Discussions will encompass topics such as genetic privacy, equity in access to genetic technologies, and public perceptions of genetic engineering.